Foundry Partners’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-53,036
Closed -$589K 394
2018
Q2
$589K Sell
53,036
-250
-0.5% -$2.56K 0.02% 339
2018
Q1
$488K Sell
53,286
-377
-0.7% -$3.45K 0.02% 349
2017
Q4
$509K Sell
53,663
-2,330
-4% -$23.5K 0.02% 341
2017
Q3
$599K Buy
55,993
+3,975
+8% +$36.6K 0.02% 335
2017
Q2
$536K Sell
52,018
-857
-2% -$10.8K 0.02% 359
2017
Q1
$740K Sell
52,875
-178
-0.3% -$2.71K 0.03% 357
2016
Q4
$801K Buy
53,053
+12,630
+31% +$191K 0.03% 358
2016
Q3
$655K Buy
+40,423
New +$666K 0.03% 313

Other funds holding HHS

Foundry Partners's HHS Position: Q3 2018 in Review

Foundry Partners sold out of Harte-Hanks (HHS) in Q3 2018, closing a stake of 53,036 shares — an estimated $589K sold.

Foundry Partners first reported a position in HHS in Q3 2016 and held it in 8 quarters. The position peaked at $801K in Q4 2016. 27 funds tracked by Wall St. Rank hold HHS as of Q3 2018.

  • Foundry Partners reported no remaining Harte-Hanks position as of Q3 2018 after selling out during the quarter.
  • Foundry Partners sold 53,036 Harte-Hanks shares in Q3 2018, an estimated $589K.
  • Foundry Partners first reported a position in Harte-Hanks in Q3 2016 and held it in 8 quarters.
  • Foundry Partners's Harte-Hanks position peaked at $801K in Q4 2016.
  • 27 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2018.

Based on Foundry Partners's 13F filing for Q3 2018, filed 17 Oct 2018.